Our study is the first to evaluate MRPL23 expression patterns in PCa, demonstrating that it is overexpressed in prostate cancer tissues compared with normal adjacent tissue, with the highest levels observed in lymph node metastases (Fig. 1e). Here, MRPL23 is linked to prostate cancer.